Oxford BioDynamics

Oxford BioDynamics is a biotechnology company developing blood-based diagnostic tests and precision medicine tools built on a proprietary 3D genomics platform.

The platform interrogates chromosome conformation to identify epigenomic biomarkers predicting disease, prognosis, and therapeutic response.

Commercial products include a blood test predicting response to immune checkpoint inhibitor therapy and a prostate cancer detection test. The company also offers an AI-driven target discovery and patient stratification tool for drug developers.